4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-24-000194
Chief Medical Officer sold 22,458 shares at an average $24.49 ($549,928)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ho Carole Chief Medical Officer | 2024-08-20 | Sale 10b5-1 | −2,453 | $23.79 | $58,357 | 138,815 | D: show line 1 in the form |
| Ho Carole Chief Medical Officer | 2024-08-21 | Sale 10b5-1 | −14,098 | $24.41 | $344,132 | 124,717 | D: show line 2 in the form |
| Ho Carole Chief Medical Officer | 2024-08-21 | Sale 10b5-1 | −5,907 | $24.96 | $147,439 | 118,810 | D: show line 3 in the form |
| Open-market sales · 22,458 sh · avg $24.49 · $549,928 | |||||||
Loading xslF345X05/wk-form4_1724357642.xml…